Factors influencing deprescribing habits among geriatricians

Age and Ageing

Volumn 44, Issue 4, 2015, Pages 704-708

  Ní Chróinín, Danielle ^a   Ní Chróinín, Chantelle ^b   Beveridge, Alexander ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Dementia; Geriatrics; Inappropriate prescribing; Older people; Physician's practice patterns; Polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; DONEPEZIL; RAMIPRIL;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DEPRESCRIBING HABIT; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; GERIATRICIAN; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MALE; MEDICAL SPECIALIST; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; DEPRESCRIPTION; GERIATRICS; HABIT; INAPPROPRIATE PRESCRIBING; MANPOWER; MIDDLE AGED; PHYSICIAN; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; AGED; DEMENTIA; DEPRESCRIPTIONS; FEMALE; GERIATRICS; HABITS; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; PHYSICIANS; POLYPHARMACY; SURVEYS AND QUESTIONNAIRES;

EID: 84937440482     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afv028     Document Type: Article

References (22)

1. Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust 2012; 196: 50-3.
2. Bradley MC, Fahy T, Cahir C et al. Potnetially inappropriate prescribing and cost outcomes for older people: a crosssectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012; 68: 1425-33.
3. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-9.
4. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in a geriatric ambulatory unit. Pharmacotherapy 2000; 20: 1198-203.
5. Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med 2013; 18: 121-4.
6. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 2010; 170: 1648-54.
7. Alldred DP. Deprescribing: a brave new word? Int J Pharm Pract 2014; 22: 2-3.
8. Australian Deprescribing Network. Australian Deprescribing Network, ADeN eNewsletter. http://us7.campaign-archive1.com/?u=fd2111cc0be897c39f98a34db&id=64bb559440&e=0fa788ec71 (19 November 2014, date last accessed).
9. Department of Health. The National Strategy for Quality Use of Medicines (Plain English Version). Australian Government Department of Health, 2002. http://www.health.gov.au/internet/main/publishing.nsf/content/8ECD6705203E01BFCA257BF0001F5172/$File/natstrateng.pdf (12 October 2014, date last accessed).
10. Nair BR. Evidence based medicine for older people: available, accessible, acceptable, adaptable? Aust J Ageing 2002; 21: 58-60.
11. Beer C, Loh PK, Pneg YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Deug Saf 2011; 2: 37-43.
12. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012; 28: 237-53.
13. Reeve E, Wiese MD. Benefits of deprescribing on patients' adherence to medications. Int J Clin Pharm 2014; 36: 26-9.
14. Parsons C, McCorry N, Muprhy K et al. Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life. Int J Geriatr Psychiatry 2013; 29: 281-90.
15. Schuling J, Gebben H, Veehof LJG, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Family Practice 2012; 13: 56.
16. Shega JW, Ellner L, Lau DT, Maxwell TL. Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors. J Palliat Med 2009; 12: 779-83.
17. McLean S, Sheehy-Skeffington B, O'Leary N, O'Gorman A. Pharmacological management of co-morbid conditions at the end of life: is less more? Ir J Med Sci 2013; 182: 107-12.
18. Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013; 30: 793-807.
19. Amos TB, Keith SW, Del Canale S et al. Inappropriate prescribing in a large community-dwelling older population: a focus on prevalence and how it relates to patient and physician characteristics. J Clin Pharm Ther 2014. doi: 10.1111/jcpt.12212.
20. Coon D, Mitterer J. Chapter 3: human development. In: Coon DMitterer J, eds. Introduction to Psychology: Gateways to Mind and Behavior, 12th edition. Belmont: Wadsworth, 2010; 105-6.
21. Cohen L, Manion L, Morrison K. Surveys, longitudinal, crosssectional and trend studies. In: Cohen L, Manion L, Morrison K, eds. Research Methods in Education, 7th edition. Abingdon: Routledge, 2011; 261-4.
22. Etherton-Beer C (PI). Opti-Med: A Randomised Controlled Trial of Deprescribing to Optimise Health Outcomes for Frail Older People. http://www.australianclinicaltrials.gov.au/node/662 (12 October 2014, date last accessed).